EUVIMEDEUVIMED entdecken
Crossref

Isorhapontigenin attenuates allergic asthma by reducing airway inflammation and oxidative stress

Wen-Chung Huang, Shu-Ju Wu, Shu-Chen Cheng, Tse-Hung Huang, Chian-Jiun Liou

International Immunopharmacology · 2026

DOI: 10.1016/j.intimp.2026.116514 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2026. Verfasst von Wen-Chung Huang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Health Industry Technology, Center for Drug Research and Development, Chang Gung University of Science and Technology, Taoyuan …. Hauptthemen laut MEDLINE: Oxidative Stress, Asthma, Stilbenes, Anti-Inflammatory Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Chang Gung Memorial Hospital, National Science and Technology Council, Chang Gung University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gnetum cleistostachyum has been used in traditional Chinese medicine to treat arthritis and bronchitis. Isorhapontigenin, a naturally occurring stilbenoid structurally related to resveratrol, is isolated from G. cleistostachyum and has been reported to exhibit anti-inflammatory and antioxidant properties. Here, we examined whether isorhapontigenin can ameliorate airway inflammation, oxidative stress, and airway hyperresponsiveness (AHR) in an ovalbumin (OVA)-induced mouse model of allergic asthma. Female BALB/c mice were sensitized and challenged with OVA and subsequently administered isorhapontigenin. Lung function and AHR were evaluated, along with histopathological alterations. Inflammatory profiles and oxidative stress-associated indices were determined using bronchoalveolar lavage fluid (BALF) and lung tissues. Complementary in vitro studies were conducted in human bronchial epithelial BEAS-2B cells to assess cytokine-related responses, intracellular reactive oxygen species (ROS) generation, and monocyte-epithelial adhesion. Isorhapontigenin treatment markedly improved AHR and mitigated airway pathology in asthmatic mice, including inflammatory cell influx, mucus-producing goblet cell expansion, and airway remodeling features such as collagen accumulation. Consistently, BALF analysis showed reduced Th2-associated cytokines, eotaxins, and other pro-inflammatory mediators. Isorhapontigenin also alleviated oxidative stress-related disturbances and was associated with improved inflammatory status in lung tissues. In BEAS-2B cells, isorhapontigenin suppressed the expression of eotaxins, intercellular adhesion molecule-1, and pro-inflammatory cytokines, accompanied by decreased ROS production and reduced monocyte adhesion. These data indicate that isorhapontigenin attenuates key asthma phenotypes by concurrently dampening inflammatory responses and oxidative stress. Isorhapontigenin may therefore represent a promising candidate for the development of adjunctive strategies for asthma management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oxidative StressAsthmaStilbenesAnti-Inflammatory AgentsAntioxidantsFemaleAnimalsMiceMice, Inbred BALB CDisease Models, AnimalOvalbuminLungBronchoalveolar Lavage FluidCytokinesReactive Oxygen Species

Stichwörter der Autor:innen

Airway hyperresponsivenessAirway inflammationAsthmaIsorhapontigeninOxidative stress

Substanzen

isorhapontigeninStilbenesAnti-Inflammatory AgentsOvalbuminAntioxidantsCytokinesReactive Oxygen Species

Autor:innen und Institutionen

  • Graduate Institute of Health Industry Technology, Center for Drug Research and Development, Chang Gung University of Science and Technology, Taoyuan City, Taiwan; Department of Traditional Chinese Medicine, Chang Gung M…
  • Department of Nutrition and Health Sciences, Center for Drug Research and Development, Chang Gung University of Science and Technology, Taoyuan City, Taiwan; Aesthetic Medical Center, Department of Dermatology, Chang Gu…
  • Department of Traditional Chinese Medicine, Chang Gung Memorial Hospital, Taoyuan City, Taiwan; Department of Nursing, Division of Basic Medical Sciences, Center for Drug Research and Development, Chang Gung University…

Förderung

  • Chang Gung Memorial Hospital
  • National Science and Technology Council
  • Chang Gung University

Zitieren

APA

Huang, W. C., Wu, S. J., Cheng, S. C., Huang, T. H., & Liou, C. J. (2026). Isorhapontigenin attenuates allergic asthma by reducing airway inflammation and oxidative stress. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2026.116514

Vancouver

Huang WC, Wu SJ, Cheng SC, Huang TH, Liou CJ. Isorhapontigenin attenuates allergic asthma by reducing airway inflammation and oxidative stress. International Immunopharmacology. 2026. doi:10.1016/j.intimp.2026.116514

BibTeX
@article{Huang2026,
  author = {Huang, Wen-Chung and Wu, Shu-Ju and Cheng, Shu-Chen and Huang, Tse-Hung and Liou, Chian-Jiun},
  title = {Isorhapontigenin attenuates allergic asthma by reducing airway inflammation and oxidative stress},
  journal = {International Immunopharmacology},
  year = {2026},
  doi = {10.1016/j.intimp.2026.116514}
}
Kostenlos starten →